TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Thickness of Rectus Femoris Muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Thickness of vastus intermedius muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Cross-sectional area of Rectus Femoris Muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Oral temperature immediately postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnosis of diffuse coronary artery disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Quantification of cardiac remodeling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time to Composite of All-cause Mortality or Cardiac Hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: Change from baseline in fasting plasma glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from baseline in postprandial glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change From Baseline in the 17-item HAM-D Total Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Change From Baseline in Best Corrected Visual Acuity (BCVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time from diagnosis to surgery
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Staffelstein Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of clinically significant prostate cancer confirmed on biopsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Time to metastases in men with prostate cancer
Endpoint domain: Mortality/survival
Primary endpoint: Time to prostate cancer related death
Endpoint domain: Mortality/survival
Primary endpoint: Safety of the Implementation of MSV
Endpoint domain: Adverse events/effects
Primary endpoint: Phone Call Completion Rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Accuracy of Respiratory Rate (RR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Frequency and incidence of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Accuracy of the AVERT PLUS CM system to quantify contrast volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: amount of Tetrix remaining on the skin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiac structure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Summed Pain Intensity Difference (SPID) Over 0 to 48 Hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tissue viability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decreased occurrence of iatrogenic events
Endpoint domain: Adverse events/effects
Primary endpoint: Fusion Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Arthrodesis Rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Mean Total Administration Time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: severity of angiographically-defined coronary lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in clinical laboratory tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of TFPI plasma level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Safety of Myocel following implantation
Endpoint domain: Adverse events/effects
Primary endpoint: Recovering Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiopulmonary bypass (CPB) time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Aortic clamping (AC) time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Concordance of classification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Serious Medication Errors
Endpoint domain: Adverse events/effects
Primary endpoint: Willingness to Participate in Research
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Rate of COVID-19 nosocomial infection
Endpoint domain: Adverse events/effects
Primary endpoint: Technical success rate of endoscopic procedures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Adverse events rate of endoscopic procedures
Endpoint domain: Adverse events/effects
Primary endpoint: Technical adequacy and diagnostic quality of PB127 images
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of active periods of cluster headache
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of active periods
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of attacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Daily Step Count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Systemic concentration of study drug
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC of study drug
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Change in UPDRS II Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Maternal Responsiveness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Acne Scar Assessment Scale (ASAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physician Global Aesthetic Improvement Scale (PGAIS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Quality of Life Impact Scar (QOLIS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Analgesia assessed using the pain scale 1-10
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mood symptom improvement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cocaine or methamphetamine cravings and use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in TeloTAGGG Telomerase PCR activity in serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of average VAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Penetration degree of cervical pedicle screws
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Complications of MI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Non-CABG major bleeding during hospitalization
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Food reward
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Best Response (BR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain on the VAS scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants in Each Clinical Response Category
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Center of ventilation (COV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Hemoglobin A1C (HbA1C, %)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mini Mental State MMSE
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Digit span
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: PASAT (Naegele and Mazza, 2004)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Incidence of Dose-limiting Toxicity (DLT) Events
Endpoint domain: Adverse events/effects
Primary endpoint: Protein levels in blood, saliva, and urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Mean of Last Six 7-point Self Monitored Blood Glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of critically ill patients enrolled per ICU per month
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in physical symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Apo B
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time to first unformed stool associated with traveler's diarrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Percent change in ADAS-cog-11
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: percentage of weeks that participants enter physical activity goals
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Sternal Bone Healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in participants' HIV testing uptake
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of moderate and severe OHSS
Endpoint domain: Adverse events/effects
Primary endpoint: Internal Consistency
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in AUDIT-C from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in Activated Partial Thromboplastin Time (aPTT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change from Baseline in Endogenous Thrombin Potential (ETP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change from Baseline in Peak Thrombin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Disease recurrence (local and distant)
Endpoint domain: Mortality/survival
Primary endpoint: Number of participants experiencing clinical and laboratory adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum Tolerated Dose (MTD) of Hsp90 inhibitor AUY922
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants with somatic mutations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: healing times from pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Brain Activation Patterns in Verbal Tasks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in Brain Activation Patterns in Visual Tasks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Serum Creatinine Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Changes in protein or histone acetylation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of UCC Visits
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Maximum tolerated dose of vandetanib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Identification of vasospasm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Change From Baseline to Endpoint in the International Index of Erectile Function (IIEF)- Erectile Function Domain Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in the Sexual Quality of Life in the Subject and His Study Partner as Measured by the Sexual Quality of Life (SQoL) Domain
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change From Baseline to Endpoint in the Percent of Yes Responses to Sexual Encounter Profile (SEP) Diary Questions 2 and 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal phonation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of dose limiting toxicities (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Days Hospitalized or Dead
Endpoint domain: Mortality/survival
Primary endpoint: Improvement of nutritional status of children
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Weight Bearing Asymmetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Circadian melatonin rhythm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Circadian cortisol rhythms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Circadian analytes rhythms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of all adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in Gross Motor Function Measure (GMFM-66)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients reporting intra-operative complications
Endpoint domain: Adverse events/effects
Primary endpoint: Number of treated patients reporting post-operative adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Patient healing time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of complication in Cytrix treated patients compared to patients in the historical control group
Endpoint domain: Adverse events/effects
Primary endpoint: Patient satisfaction after Pelvic Organ Prolapse surgery using Cytrix
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Comparison of phone patient questionnaire results between Cytrix Group and Control Group
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Amount of radiolabelled drug in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Amount of radiolabelled drug in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Amount of radiolabelled drug in feces
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Radiation Treatment Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient reported score on functional outcome scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Patient reported score on cosmetic outcome scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient reported pain level on Visual Analog Scale (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in patient-reported asthma related symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Breastfeeding failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reliability of Sensitivity of questionnaires
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression rates of low attenuation plaque
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: premature baby function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Magnitude of diaphragm EMG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ratio of diaphragm EMG to tidal volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood Glucose level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Relative Tumor volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Osteoporosis status discrimination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective Confirmed Complete or Partial Overall Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of insomnia symptoms and functional impairment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient's Perception of Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete Cytogenetic Response Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in arm impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Patients with Positive screen result
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Tolerated Dose (MTD) as determined by Dose Limiting Toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Safety as measured by number of patients with at least one adverse events (incidence)
Endpoint domain: Adverse events/effects
Primary endpoint: Safety as measured by number of deaths
Endpoint domain: Mortality/survival
Primary endpoint: Improvement in participant's knowledge of lymphedema
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Total girth differences as assessed by BUE circumferential measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Combined Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Percent of subjects in each endometrial biopsy diagnostic category
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in endometrial thickness (mm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Angle of head inclination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ocular Comfort
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acoustic index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fibrosis in vitreal sides of Internal Limiting Membranes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in area under the adenosine dose response curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: undercarboxylated osteocalcin (ucOC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Lumen Late Loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Histological proof of neoplastic tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of Participants With Non-serious Adverse Events or Serious Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Successful Induced Ventricular Fibrillation Conversion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Acceptability of eProtocol-insulin instructions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of glucose values < 40 mg/dl
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of near-falls
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: driving parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Failure-free Survival at 5 Years
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of complications / adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Local and Generalized Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Comfort levels
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Confirmed Response Rate (CR or PR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Percentage of Participants Vaccinated
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minimal Residual Disease as Assessed by Bone Marrow Flow Cytometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary Ischemic Endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Primary Bleeding Endpoint
Endpoint domain: Adverse events/effects
Primary endpoint: Difference in Blood Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cumulative Somatosensory Impairment Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Health Status Perception
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: overall and disease-free survival
Endpoint domain: Mortality/survival
Primary endpoint: incidence of locoregional recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: short- and long-term complications
Endpoint domain: Adverse events/effects
Primary endpoint: Activities-Specific Balance Confidence (ABC) Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Average daily number of steps
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expression of CD39 and adenosinergic receptors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expression of PGC-1 alpha and mitochondrial markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes